QC
FLNA

Quadrature Capital’s Filana Therapeutics FLNA Stock Holding History

Quadrature Capital’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.4K Buy
+11,238
New +$16K ﹤0.01% 1539

Other funds holding FLNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $6.06B AUM 28.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AWM
Apollon Wealth Management Mount Pleasant, South Carolina $8.23B AUM 30.88% 1-Year Est. Return
ML
Mayport LLC Newton, Massachusetts $645M AUM 19.45% 1-Year Est. Return
JIC
Johnson Investment Counsel Cincinnati, Ohio $13.7B AUM 21.52% 1-Year Est. Return
AWM
Activest Wealth Management Aventure, Florida $518M AUM 44.34% 1-Year Est. Return

Quadrature Capital's FLNA Position: Q2 2026 in Review

Quadrature Capital opened a new position in Filana Therapeutics (FLNA) in Q2 2026: 11,238 shares worth $13.4K. The stake represents ﹤0.01% of the portfolio and ranks #1539 among its holdings.

31 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • Quadrature Capital held 11,238 shares of Filana Therapeutics worth $13.4K as of Q2 2026.
  • Filana Therapeutics was a new Quadrature Capital position in Q2 2026.
  • Filana Therapeutics made up ﹤0.01% of Quadrature Capital's portfolio in Q2 2026, its #1539 holding.
  • 31 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on Quadrature Capital's 13F filing for Q2 2026, filed 7 Aug 2026.